Biotronik (Lake Oswego, Oregon) is hoping that the addition of its established Closed Loop Stimulation (CLS) sensor in the latest generation of its Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices will give it a leg up on the competition in the global cardiac pacemakers sector, which is projected to reach $5.7 billion by next year, according to Research and Markets. Read More
